Oxymorphone hydrochloride

Product NDC: 63304-223
11-digit product format: 633040223
Labeler code: 63304
Product ID: 63304-223_b6f91a0b-ca7e-4af1-8ea6-741af2050314
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Oxymorphone hydrochloride
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Labeler: Ranbaxy Pharmaceuticals Inc.
Application: ANDA203506
Marketing category: ANDA
Marketing start: 2015-04-13
Marketing end: 0000-00-00
Substance: OXYMORPHONE HYDROCHLORIDE
Active strength: 30 mg/1
Pharmacologic classes: Full Opioid Agonists [MoA],Opioid Agonist [EPC]
DEA schedule: CII
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	63304-223		I	Inactivated by FDA	2026-10-05
excluded package	package	63304-223	63304-223-05	I	Inactivated by FDA	2026-10-05
excluded package	package	63304-223	63304-223-30	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 66 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63304-223-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63304-223-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63304-223-05	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63304-223-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63304-223-05	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63304-223-30	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63304-223-05	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63304-223-30	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63304-223-05	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63304-223-30	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63304-223-05	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63304-223-30	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63304-223-05	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63304-223-30	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63304-223-05	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63304-223-30	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63304-223-05	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63304-223-30	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63304-223-05	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63304-223-30	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63304-223-05	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63304-223-30	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63304-223-05	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63304-223-30	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	63304-223-05	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	63304-223-30	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	63304-223-05	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	63304-223-30	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	63304-223-05	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	63304-223-30	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	63304-223-05	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	63304-223-30	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	63304-223-05	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	63304-223-30	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	63304-223-05	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	63304-223-30	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	63304-223-05	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	63304-223-30	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	63304-223-05	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	63304-223-30	`e2bbac7714bc…`	`27bdfed8d636…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 7 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A203506-001	OXYMORPHONE HYDROCHLORIDE	OXYMORPHONE HYDROCHLORIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24
A203506-002	OXYMORPHONE HYDROCHLORIDE	OXYMORPHONE HYDROCHLORIDE	7.5MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24
A203506-003	OXYMORPHONE HYDROCHLORIDE	OXYMORPHONE HYDROCHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24
A203506-004	OXYMORPHONE HYDROCHLORIDE	OXYMORPHONE HYDROCHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24
A203506-005	OXYMORPHONE HYDROCHLORIDE	OXYMORPHONE HYDROCHLORIDE	20MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24
A203506-006	OXYMORPHONE HYDROCHLORIDE	OXYMORPHONE HYDROCHLORIDE	30MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24
A203506-007	OXYMORPHONE HYDROCHLORIDE	OXYMORPHONE HYDROCHLORIDE	40MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 8 · 301 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A203506-001	OXYMORPHONE HYDROCHLORIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203506-002	OXYMORPHONE HYDROCHLORIDE	7.5MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203506-003	OXYMORPHONE HYDROCHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203506-004	OXYMORPHONE HYDROCHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203506-005	OXYMORPHONE HYDROCHLORIDE	20MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203506-006	OXYMORPHONE HYDROCHLORIDE	30MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203506-007	OXYMORPHONE HYDROCHLORIDE	40MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A203506-001	OXYMORPHONE HYDROCHLORIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203506-002	OXYMORPHONE HYDROCHLORIDE	7.5MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203506-003	OXYMORPHONE HYDROCHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203506-004	OXYMORPHONE HYDROCHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203506-005	OXYMORPHONE HYDROCHLORIDE	20MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203506-006	OXYMORPHONE HYDROCHLORIDE	30MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203506-007	OXYMORPHONE HYDROCHLORIDE	40MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203506-001	OXYMORPHONE HYDROCHLORIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203506-002	OXYMORPHONE HYDROCHLORIDE	7.5MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203506-003	OXYMORPHONE HYDROCHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203506-004	OXYMORPHONE HYDROCHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203506-005	OXYMORPHONE HYDROCHLORIDE	20MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203506-006	OXYMORPHONE HYDROCHLORIDE	30MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203506-007	OXYMORPHONE HYDROCHLORIDE	40MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203506-001	OXYMORPHONE HYDROCHLORIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203506-002	OXYMORPHONE HYDROCHLORIDE	7.5MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203506-003	OXYMORPHONE HYDROCHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203506-004	OXYMORPHONE HYDROCHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203506-005	OXYMORPHONE HYDROCHLORIDE	20MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203506-006	OXYMORPHONE HYDROCHLORIDE	30MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203506-007	OXYMORPHONE HYDROCHLORIDE	40MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203506-001	OXYMORPHONE HYDROCHLORIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203506-002	OXYMORPHONE HYDROCHLORIDE	7.5MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203506-003	OXYMORPHONE HYDROCHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203506-004	OXYMORPHONE HYDROCHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203506-005	OXYMORPHONE HYDROCHLORIDE	20MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203506-006	OXYMORPHONE HYDROCHLORIDE	30MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203506-007	OXYMORPHONE HYDROCHLORIDE	40MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203506-001	OXYMORPHONE HYDROCHLORIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203506-002	OXYMORPHONE HYDROCHLORIDE	7.5MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203506-003	OXYMORPHONE HYDROCHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203506-004	OXYMORPHONE HYDROCHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203506-005	OXYMORPHONE HYDROCHLORIDE	20MG	TABLET, EXTENDED RELEASE / ORAL	2015-04-24	`fd3edfee7708…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
52f0f025-f368-4487-8f9b-49af2656aeeb	Product name	3	20201015
3792daf4-c308-47ef-a996-98dc7faa1671	Product name	2	20150511
0476a93f-c9eb-691e-8ebf-e5b816d8f47b	Product name	1	20140508
a4b9889e-23ea-ee9f-05f6-4b861fda077b	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63304-223-05	2020-01-31	C162847	48780-1	9d75b9d0-c81a-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use OXYMORPHONE hydrochloride Extended-Release Tablets safely and effectively. See full prescribing information for OXYMORPHONE hydrochloride Extended-Release Tablets. OXYMORPHONE hydrochloride Extended-Release Tablets, for oral use, CII Initial U.S. Approval: 1959
63304-223-30	2020-01-31	C162847	48780-1	9d75b9d0-c81a-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use OXYMORPHONE hydrochloride Extended-Release Tablets safely and effectively. See full prescribing information for OXYMORPHONE hydrochloride Extended-Release Tablets. OXYMORPHONE hydrochloride Extended-Release Tablets, for oral use, CII Initial U.S. Approval: 1959

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
63304-223-05	Oxymorphone hydrochloride	500 in 1 BOTTLE	TABLET, FILM COATED, EXTENDED RE	500		6
63304-223-30	Oxymorphone hydrochloride	30 in 1 BOTTLE	TABLET, FILM COATED, EXTENDED RE	30		6

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
OXYMORPHONE HYDROCHLORIDE	ACTIVE INGREDIENT	5Y2EI94NBC	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4
OXYMORPHONE	ACTIVE MOIETY	9VXA968E0C	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4
SODIUM STEARYL FUMARATE	INACTIVE INGREDIENT	7CV7WJK4UI	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63304-223	OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC.]	6	Legacy NDC, 2 package rows	20170124_e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
5Y2EI94NBC	OXYMORPHONE HYDROCHLORIDE	357-07-3	OXYMORPHONE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
977874	oxyMORphone HCl 10 MG 12HR Extended Release Oral Tablet	PSN	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977894	oxyMORphone HCl 15 MG 12HR Extended Release Oral Tablet	PSN	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977902	oxyMORphone HCl 20 MG 12HR Extended Release Oral Tablet	PSN	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977909	oxyMORphone HCl 30 MG 12HR Extended Release Oral Tablet	PSN	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977915	oxyMORphone HCl 40 MG 12HR Extended Release Oral Tablet	PSN	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977923	oxyMORphone HCl 5 MG 12HR Extended Release Oral Tablet	PSN	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977929	oxyMORphone HCl 7.5 MG 12HR Extended Release Oral Tablet	PSN	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977874	12 HR oxymorphone hydrochloride 10 MG Extended Release Oral Tablet	SCD	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977894	12 HR oxymorphone hydrochloride 15 MG Extended Release Oral Tablet	SCD	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977902	12 HR oxymorphone hydrochloride 20 MG Extended Release Oral Tablet	SCD	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977909	12 HR oxymorphone hydrochloride 30 MG Extended Release Oral Tablet	SCD	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977915	12 HR oxymorphone hydrochloride 40 MG Extended Release Oral Tablet	SCD	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977923	12 HR oxymorphone hydrochloride 5 MG Extended Release Oral Tablet	SCD	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977929	12 HR oxymorphone hydrochloride 7.5 MG Extended Release Oral Tablet	SCD	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977874	oxymorphone hydrochloride 10 MG 12 HR Extended Release Oral Tablet	SY	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977894	oxymorphone hydrochloride 15 MG 12 HR Extended Release Oral Tablet	SY	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977902	oxymorphone hydrochloride 20 MG 12 HR Extended Release Oral Tablet	SY	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977909	oxymorphone hydrochloride 30 MG 12 HR Extended Release Oral Tablet	SY	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977915	oxymorphone hydrochloride 40 MG 12 HR Extended Release Oral Tablet	SY	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977923	oxymorphone hydrochloride 5 MG 12 HR Extended Release Oral Tablet	SY	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6
977929	oxymorphone hydrochloride 7.5 MG 12 HR Extended Release Oral Tablet	SY	e6b1c980-bb0c-4805-8e0d-9f8f8e9bfdde	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
63304-223-05	63304022305	500 in 1 BOTTLE	Historical
63304-223-30	63304022330	30 in 1 BOTTLE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Oxymorphone hydrochloride	Ranbaxy Pharmaceuticals Inc. \| Ohm Laboratories Inc._Terminal	2016-09-13	HUMAN PRESCRIPTION DRUG LABEL	6